主页 > 医学动态 >
【技术产业】制药公司采用新的方法来应对FDA的
http://onlypunjab.com/fullstory2k5-insight-Pharmaceutical+Companies-status-20-newsID-114746.html
Pharmaceutical Companies Now Have Additional Tools from STAT-A-MATRIX to Satisfy FDA Compliance
Compliance with recent FDA regulations designed to reduce health risks to the public.
The pharmaceutical industry is one of the most regulated industries in the U.S. It faces rigorous Federal Food and Drug Administration (FDA) scrutiny. The latest changes to modernize FDA's policies and regulations are designed to assure product safety; understanding how to comply with them is a challenge facing any business covered by the regulations.
Pharmaceutical manufacturers are still learning how to satisfy the new regulations and how to handle their vulnerability to public crises and international compliances issues.
New two-day seminars specifically for pharmaceutical companies simplify recent FDA regulation changes
- Lean Six Sigma for FDA's PAT Initiatives
- Understanding FDA's CGMP for Finished Pharmaceuticals
- Risk Management and Analysis for Pharmaceuticals
All new programs are available for delivery as public seminars or at the client's location.
our clients expect STAT-A-MATRIX training and consulting to help them go beyond regulatory compliance to business excellence. Our newest seminars simplify FDA compliance while demonstrating techniques for performance improvement,?said Ernani Pires, president of STAT-A-MATRIX. These programs expand our offerings in FDA-regulated practice areas to help current and future clients.
These services developed exclusively for the pharmaceutical industry include seminars and consulting in all areas of FDA compliance and crises intervention.
STAT-A-MATRIX is the world's leading consulting and training organization dedicated to the pursuit of business process improvement, performance excellence, and regulatory compliance.
It offers ongoing consulting and training in every aspect of business process improvement, from the basics to the specialized tools needed to assure both customer satisfaction and regulatory or standards compliance. For more information, please visit www.statamatrix.com. 认领,试试 Pharmaceutical Companies Now Have Additional Tools from STAT-A-MATRIX to Satisfy FDA Compliance
制药公司从STAT-A-MATRIX公司（美国著名咨询公司）那里得到新的方法来对满足FDA的服从原则
Compliance with recent FDA regulations designed to reduce health risks to the public.
FDA为了减少大众的健康风险而出台的最新的服从规则。
The pharmaceutical industry is one of the most regulated industries in the U.S. It faces rigorous Federal Food and Drug Administration (FDA) scrutiny.
制药产业是美国管理最严格的行业之一，必须面对FDA严格的审查。
The latest changes to modernize FDA's policies and regulations are designed to assure product safety; understanding how to comply with them is a challenge facing any business covered by the regulations.
FDA最新的政策修改旨在确保产品的安全性；理解如何应对这些政策，是摆在这些企业面前巨大的挑战。
Pharmaceutical manufacturers are still learning how to satisfy the new regulations and how to handle their vulnerability to public crises and international compliances issues.
制药企业仍然要不断学习怎样符合规则的要求，以及如何处理在应对公众危机和国际服从协议中的不足。
New two-day seminars specifically for pharmaceutical companies simplify recent FDA regulation changes
在近期召开的为期两天的研讨会上,我们明确地为制药公司解释了最近FDA规则的变化。
- Lean Six Sigma for FDA's PAT(Process Analytical Technology) Initiatives
-依靠六西格玛管理理论为FDA的"过程分析技术提案"服务
- Understanding FDA's CGMP(current Good Manufacture Practice) for Finished Pharmaceuticals
-理解FDA的医药产品的动态药品生产管理规范
- Risk Management and Analysis for Pharmaceuticals
-医药产品的风险管理和分析
All new programs are available for delivery as public seminars or at the client's location.
所有新的课程均可以在公共研讨会或客户指定场所授课。
our clients expect STAT-A-MATRIX training and consulting to help them go beyond regulatory compliance to business excellence.
我们的客户希望SAM培训咨询公司能够帮助他们超越服从规则，达到商业成功。
Our newest seminars simplify FDA compliance while demonstrating techniques for performance improvement,said Ernani Pires, president of STAT-A-MATRIX. These programs expand our offerings in FDA-regulated practice areas to help current and future clients.
阅读本文的人还阅读：
作者:admin@医学,生命科学 2010-12-23 17:11
医学,生命科学网